Show Summary Details
Page of

Medical ethics in oncology 

Medical ethics in oncology
Medical ethics in oncology

Eric A. Singer


March 29, 2019: This chapter has been re-evaluated and remains up-to-date. No changes have been necessary.

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 08 July 2020

This chapter reviews several fundamental dilemmas in oncology practice. It describes the foundational codes of research ethics that have shaped our current clinical trials system and the moral reasoning used to justify the use of human subjects in early-phase oncology research, placebo-controlled trials, and mandatory research biopsies. The second part of this chapter examines two contemporary problems: oncology drug shortages and the cost of cancer care. The chapter concludes with a section describing additional ethics resources and emphasizes the importance of early ethics consultation to avoid situations that could potentially place patients or research subjects at increased risk of harm.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.